Skip to main content
HR 7217 115th Congress House Health Birth defects Blood and blood diseases Business records Cardiovascular and respiratory health Child health Civil actions and liability Disability and paralysis Emergency medical services and trauma care Family services HIV/AIDS Health care costs and insurance Health care coverage and access Health care quality Health personnel Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Hereditary and development disorders Home and outpatient care

IMPROVE Act

Introduced: December 6, 2018 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 11 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 12, 2018
Received in the Senate.
Dec 11, 2018
Motion to reconsider laid on the table Agreed to without objection.
Dec 11, 2018
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 400 - 11 (Roll no. 428). (text: CR H10043-10047)
Dec 11, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 400 - 11 (Roll no. 428).(text: H10043-10047)
Dec 11, 2018
Considered as unfinished business. (consideration: CR H10083)
Dec 11, 2018
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 11, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 7217.
Dec 11, 2018
Considered under suspension of the rules. (consideration: CR H10043-10052)
Dec 11, 2018
Mr. Barton moved to suspend the rules and pass the bill.
Dec 6, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 6, 2018
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Dec 11, 2018 House · vote #428 On Motion to Suspend the Rules and Pass Passed 400–11 See who voted →
 Plain-English summary Congressional Research Service

Improving Medicaid Programs and Opportunities for Eligible Beneficiaries Act or the IMPROVE Act

This bill establishes a state Medicaid option to provide for medical assistance with respect to coordinated care provided through a health home (i.e., a designated provider or team of health-care professionals) for children with medically complex conditions. States must determine payment methodologies in accordance with specified requirements; payments also temporarily qualify for an enhanced federal matching rate.

The bill also makes a series of reductions relating to federal Medicaid expenditures. Among other changes, the bill reduces the federal matching rate for states that do not have required asset-verification programs for determining Medicaid eligibility.

Further, drug manufacturers with Medicaid rebate agreements for covered outpatient drugs must disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).

Finally, the bill excludes specified wheelchairs and associated accessories from Medicare's competitive acquisition program (in which rates are set through a competitive bidding program rather than by an established fee schedule).

What's happening now December 12, 2018

Received in the Senate.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 2 Republican 2